« Return to News | CROs/Service Providers

Patient Recruiters International opens office in Southeast Asia

Monday, June 25, 2012 09:46 AM

Patient Recruiters International (PRI), a provider of direct patient access solutions for patient recruitment, has opened its new Southeast Asian office in Bangkok, Thailand.

The strategic location gives PRI central access to India, Singapore, China, Hong Kong, South Korea, Taiwan, Japan and Indonesia. PRI Asia is located within minutes of four international hospitals that service over 3 million patient visits per year and nearly 1 million medical tourists for tertiary care and rare diseases.

“We are excited to begin our direct presence in Asia by offering clinical site selection, site management and patient recruitment services through our office in Bangkok, Thailand,” said Larry Risen, president of PRI. “Bangkok possesses world class international hospitals with a high volume of…patients. The economics of conducting clinical trials in Thailand and other Southeast Asian markets is very favorable: the quality of research is good and the clinical sites are ICH/GCP compliant. This location is ideal for investigator meetings and workshops for clinical sites throughout Southeast Asia.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.